Last reviewed · How we verify
NCT05085821: HEART
Cardio-visual Stimulation in Augmented Reality for Pain Reduction
NA trial testing HEART in Regional Pain Syndrome in 32 participants. Completed in 29 June 2023.
29 June 2023
Quick facts
| Lead sponsor | Union de Gestion des Etablissements des Caisses d'Assurance Maladie - Nord Est |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 32 |
| Start date | 20 April 2021 |
| Primary completion | 29 June 2023 |
| Estimated completion | 29 June 2023 |
| Sites | 1 location across France |
Drugs / interventions tested
- HEART
- Placebo
Conditions studied
- Regional Pain Syndrome — all drugs for Regional Pain Syndrome →
- Chronic Pain Syndrome — all drugs for Chronic Pain Syndrome →
Sponsor
Union de Gestion des Etablissements des Caisses d'Assurance Maladie - Nord Est
Who can join
18 and older, any sex, with Regional Pain Syndrome or Chronic Pain Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective of this study is to evaluate the feasibility and efficacy of an Augmented Reality (AR) biofeedback intervention to alleviate pain symptoms in individuals suffering from chronic pain of the hand and/or the forearm.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05085821
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of HEART
Trials testing the same drug.
- NCT04156516 — Longitudinal Effects of a Sexual Health Intervention: HEART · NA · terminated
- NCT03453515 — Reducing HIV Risk Among Adolescents: Evaluating HEART for Teens · NA · completed
Other Union de Gestion des Etablissements des Caisses d'Assurance Maladie - Nord Est trials
Trials by the same sponsor.
- NCT07191795 — Uses of Phantom Sensations Induced by Global and Local Modifications of the Prosthetic Socket as Somatosensory Feedback · NA · recruiting
- NCT06438432 — Trunk Activity Rehabilitation in Young Children With Cerebral Palsy · NA · recruiting
- NCT05650398 — Changes in Tactile Perception in People With Segmental Exclusion Syndrome · completed
- NCT05224232 — Protocole Access-Socket · NA · completed
- NCT04778111 — Segmental Exclusion of the Upper Limb and Peri-personal Space · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05085821 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Union de Gestion des Etablissements des Caisses d'Assurance Maladie - Nord Est
- Last refreshed: 6 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05085821.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing